Preet Bipinchandra Patel
About Preet Bipinchandra Patel
Data last updated:
Preet Bipinchandra Patel is a Director at Elixir Pharma Chem Private Limited (since 2023), Additional Director at Orka Pharmaceuticals Private Limited (since 2025) and Additional Director at Chimerical Lifesciences Private Limited (since 2021), and holds 5 more current directorships. The companies operate in Pharma, Chemicals and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹41.16 Cr; the largest is Elixir Pharma Chem Private Limited at ₹41.04 Cr (FY 2025). Earlier, Preet Bipinchandra Patel was an Additional Director at Jvka Industries Private Limited (2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Elixir Pharma Chem Private Limited U46497GJ2023PTC143193 | Director | 24 Jul 2023 | 2023 | ₹41.04 Cr (FY 2025) | Active |
 Orka Pharmaceuticals Private Limited U24290GJ2022PTC131876 | Additional Director | 29 Aug 2025 | 2022 | ₹8.7 Lakh (FY 2024) | Active |
| Chimerical Lifesciences Private Limited U74993GJ2018PTC102513 | Additional Director | 06 Jan 2021 | 2018 | ₹3.4 Lakh (FY 2020) | Active |
| Xbattery Energy Private Limited U27201TS2024PTC188309 | Nominee Director | 01 Oct 2025 | 2024 | Active | |
| Altravia Global Private Limited U46620GJ2025PTC163662 | Director | 03 Jun 2025 | 2025 | Active | |
| Pranav Chemicals (India) Private Limited U20297GJ2024PTC156131 | Director | 30 Oct 2024 | 2024 | Active | |
| Arpan Luxe Llp ACA-6329 | Partner | 18 Apr 2023 | 2023 | Active | |
| Arpan Life Space Llp AAV-6709 | Partner | 02 Feb 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jvka Industries Private Limited U21000GJ2024PTC147445 | Additional Director | 01 Jan 2025 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Preet Bipinchandra Patel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Preet Bipinchandra Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Preet Bipinchandra Patel
Preet Bipinchandra Patel currently holds 8 directorships: Elixir Pharma Chem Private Limited (Director, since 24 Jul 2023, revenue ₹41.04 Cr (FY 2025)); Orka Pharmaceuticals Private Limited (Additional Director, since 29 Aug 2025, revenue ₹8.7 Lakh (FY 2024)); Chimerical Lifesciences Private Limited (Additional Director, since 06 Jan 2021, revenue ₹3.4 Lakh (FY 2020)); Xbattery Energy Private Limited (Nominee Director, since 01 Oct 2025); Altravia Global Private Limited (Director, since 03 Jun 2025); and 3 more.
Preet Bipinchandra Patel was first appointed on 06 Jan 2021 as Additional Director at Chimerical Lifesciences Private Limited. The most recent appointment on record is 01 Oct 2025 at Xbattery Energy Private Limited.
The 3 current companies of Preet Bipinchandra Patel that report revenue have a combined latest revenue of ₹41.16 Cr: Elixir Pharma Chem Private Limited ₹41.04 Cr (FY 2025); Orka Pharmaceuticals Private Limited ₹8.7 Lakh (FY 2024); Chimerical Lifesciences Private Limited ₹3.4 Lakh (FY 2020).
Preet Bipinchandra Patel held 1 earlier board appointment: Jvka Industries Private Limited (Additional Director, 01 Jan 2025 to 20 Apr 2025).
The current boards of Preet Bipinchandra Patel's companies include Beenaben Bipinchandra Patel (Elixir Pharma Chem Private Limited), Bipinchandra Kacharabhai Patel (Elixir Pharma Chem Private Limited), Daleep Kumar Malhotra (Elixir Pharma Chem Private Limited), Mohik Somabhai Patel (Orka Pharmaceuticals Private Limited), Snehalben Pravinbhai Patel (Orka Pharmaceuticals Private Limited), Mahesh Jayantibhai Prajapati (Chimerical Lifesciences Private Limited), among others.